Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Mar; 160(1)

  • Pavel Sistika, Miroslav Turjapb, Andreea Maria Iordachea, Helena M.E.B. Saldanhaa, Karel Lemra, Petr Bednara
  • Published 2016


Background. Psychiatric disorders contribute significantly to worldwide morbidity and mortality. In the case of depression and schizophrenia, effective drug therapy is available but 30–50% of patients do not respond sufficiently to the initial treatment regimen. Apart from the development of new molecules, it is desirable to optimize treatment outcomes with… (More)


2 Figures and Tables